Caribou Biosciences (CRBU) Shareholder's Equity Growth (1y) (2021 - 2026)
Caribou Biosciences (CRBU) Shareholder's Equity Growth (1y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Caribou Biosciences |
156.73 Mn |
39.11 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-53.04% |
| Dec 31, 2025 |
-51.70% |
| Sep 30, 2025 |
-49.56% |
| Jun 30, 2025 |
-46.49% |
| Mar 31, 2025 |
-36.72% |
| Dec 31, 2024 |
-31.34% |
| Sep 30, 2024 |
-29.39% |
| Jun 30, 2024 |
15.22% |
| Mar 31, 2024 |
23.36% |
| Dec 31, 2023 |
22.44% |
| Sep 30, 2023 |
22.88% |
| Jun 30, 2023 |
-22.54% |
| Mar 31, 2023 |
-25.15% |
| Dec 31, 2022 |
-22.42% |
| Sep 30, 2022 |
-19.85% |
| Jun 30, 2022 |
829.46% |
| Mar 31, 2022 |
1,141.77% |
| Dec 31, 2021 |
1,754.76% |
| Sep 30, 2021 |
3,707.18% |
| Jun 30, 2021 |
-1,201.26% |
